Evidence map›Paper›PMID 40258687›Full record

Trial reportBritish journal of haematology2025

How low can we go? Comparison of liberal and restrictive red cell transfusion thresholds in paediatric allogeneic haematopoietic stem cell transplantation: A randomized multicentre feasibility trial.

H V New, E Sanderson, V Hopkins, H Thomas, A Gassas, M Adams, B Gibson, K Patrick, R Wynn, L Hoole and 5 more

Abstract readMulticenter StudyRandomized Controlled TrialComparative Study
In one paragraph

Trial report in British journal of haematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

H V NewNHS Blood and Transplant, London, UK.ORCID https://orcid.org/0000-0001-6290-8004
E SandersonClinical Trials Unit, NHS Blood and Transplant, Cambridge, UK.
V HopkinsClinical Trials Unit, NHS Blood and Transplant, Cambridge, UK.
H ThomasClinical Trials Unit, NHS Blood and Transplant, Cambridge, UK.
A GassasDepartment of Paediatrics, Imperial College Healthcare NHS Trust, London, UK.
M AdamsDepartment of Paediatric Oncology, Children's Hospital for Wales, Cardiff, UK.
B GibsonDepartment of Haematology, Royal Hospital for Children, Glasgow, UK.
K PatrickDepartment of Paediatric Haematology, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
R WynnDepartment of Paediatric Haematology, Royal Manchester Children's Hospital, Manchester, UK.ORCID https://orcid.org/0000-0002-6046-8428
L HooleDepartment of Haematology and Oncology, Bristol Royal Hospital for Children, Bristol, UK.
H SmethurstClinical Trials Unit, NHS Blood and Transplant, Cambridge, UK.
M Lobo-ClarkeClinical Trials Unit, NHS Blood and Transplant, Cambridge, UK.
L SmithClinical Trials Unit, NHS Blood and Transplant, Cambridge, UK.
A MoraClinical Trials Unit, NHS Blood and Transplant, Cambridge, UK.
S J StanworthDepartment of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.ORCID https://orcid.org/0000-0002-7414-4950

Funding

NHS Blood and Transplant Trust Fund TF070
6 · The paper itself

Abstract

Optimal red blood cell transfusion thresholds for children with bone marrow failure are uncertain; a previous study was stopped following concerns about veno-occlusive disease. The aims of this study in allogeneic haematopoietic stem cell transplant (HSCT) were to assess feasibility of recruitment and protocol adherence (primary outcomes) for different haemoglobin (Hb) transfusion thresholds, and to describe safety and present exploratory data on quality of life (QoL). Children aged ≥1 to <18 years were randomized to restrictive Hb transfusion thresholds of 65 g/L (restrictive) vs. 80 g/L (liberal) for HSCT days 0-100. Thirty-four patients were randomized at four UK HSCT centres, 17 in each arm. 48.6% (34/70) of eligible patients were recruited (target ≥50%), with high levels of protocol adherence: % (n/N) [95% CI] in the restrictive and liberal arms were 99.2 (961/969) [98.6, 99.7] and 97.2 (1131/1164) [96.2, 98.1] respectively (target ≥70% each arm). The mean pre-transfusion Hb was 16.3 g/L higher in the liberal than in the restrictive arm. Feasibility to measure QoL was demonstrated with no evidence of more fatigue in the restrictive arm. Although the study was not powered for clinical outcomes, the findings suggest that some populations may be able to safely tolerate anaemia levels below 70 g/L, the most common restrictive transfusion threshold.

Indexed as

Erythrocyte TransfusionHematopoietic Stem Cell TransplantationAdolescentChildChild, PreschoolFeasibility StudiesFemaleHemoglobinsHumansInfantMaleQuality of LifeTransplantation, HomologousHemoglobinshaemoglobin thresholdHSCTpaediatric transfusion

Identifiers

PMID40258687
PMCPMC12166339

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.